Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Cash flows from operating activities:
Net loss	$ (3,716,105)	$ (2,684,591)	$ (13,141,074)	$ (10,067,133)
Income (loss) from discontinued operations			(2,776,013)	2,615,965
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	104,835	92,984	189,869	277,573
Amortization of intangible assets			10,251	140,437
Amortization of deferred license costs			30,589	30,589
Amortization of debt issuance costs and debt discount			611,721	476,894
Amortization of right of use asset			866,800	613,092
Gain on deconsolidation – SG DevCorp			(4,728,348)
Loss on disposition of equity-based investment			320,408
Change in fair value of equity-based investments	613,665		5,590,666
Common stock issued for services				484,825
Interest income on long-term note receivable				(21,884)
Stock-based compensation			1,097,698	3,210,631
Changes in operating assets and liabilities:
Accounts receivable			14,513	539,157
Contract assets			(173,775)	17,993
Inventories			(585,632)	63,374
Prepaid expenses and other current assets			(308,211)	310,150
Intangible assets			(23,920)	(71,761)
Accounts payable and accrued expenses			881,548	2,060,288
Contract liabilities			(611,934)	873,731
Lease liability			(1,139,751)	(925,815)
Assumed liability				15,000
Net cash used in operating activities by continuing operations			(8,322,569)	(4,588,824)
Net cash used in operating activities by discontinued operations			(1,593,347)	(83,039)
Cash flows from investing activities:
Purchase of property, plant and equipment			(8,007)	(522,715)
Cash received from sale of equity-based investment			125,000
Project development costs			(154,089)	(110,279)
Investment in and advances to equity affiliates
Net cash used in investing activities by continuing operations			(37,096)	(632,994)
Net cash used in investing activities by discontinued operations			(364,352)	(59,609)
Cash flows from financing activities:
Repurchase of common stock				(42,716)
Repayment of short term notes payable			(5,143,298)	(232,144)
Proceeds from short-term notes payable and warrants, net of debt issuance costs			8,013,745	1,401,339
Proceeds from long-term notes payable				706,359
Proceeds from warrant inducement			494,213
Prefunded warrant exercise			30
Issuance of common stock for cash			3,590,386
Issuance of common stock under EP Agreement			28,867
Distribution paid to non-controlling interest				(46,417)
Net cash provided by financing activities by continuing operations			6,983,943	1,786,421
Net cash provided by financing activities by discontinued operations			3,576,166	3,708,175
Net increase in cash and cash equivalents			242,745	130,130
Cash and cash equivalents - beginning of period			14,212	582,776	$ 582,776
Cash and cash equivalents - end of period	256,957	712,906	256,957	712,906	$ 14,212
Less: cash and cash equivalents - discontinued operations		(33,365)		(33,365)
Cash and cash equivalents - continuing operations	256,957	679,541	256,957	679,541
Assets and liabilities effected in deconsolidation
Assets held for sale			4,400,361
Cash			567,473
Prepaid expenses and other current assets			429,331
Property and equipment, net			1,194,117
Project development costs and other assets			91,490
Goodwill			1,810,787
Intangible assets			138,678
Investments in equity-based investments			3,642,607
Accounts payable and accrued expenses			1,600,294
Contingent consideration payable			945,000
Short-term notes payable			6,476,723
Cashless warrant exercise			114
Fractional common share adjustment			1
Common stock deemed dividend - inducement			670,881
Common stock deemed dividend – reduction in conversion price			475,713
Conversion of short-term notes payable to common stock			802,087	700,000
Fair value of warrants issued with debt			251,361
Common stock issuance for accounts payable settlement			1,259,681
Assets and liabilities acquired in business combination:
Intangible assets			100,468
Goodwill			1,810,787
Accounts payable and accrued expenses			532,337
Contingent consideration payable			$ 945,000